Suppr超能文献

鹅膏菌素摄取入人肝细胞的分子特征及抑制作用

Molecular characterization and inhibition of amanitin uptake into human hepatocytes.

作者信息

Letschert Katrin, Faulstich Heinz, Keller Daniela, Keppler Dietrich

机构信息

Division of Tumor Biochemistry, German Cancer Research Center, 69120 Heidelberg, Germany.

出版信息

Toxicol Sci. 2006 May;91(1):140-9. doi: 10.1093/toxsci/kfj141. Epub 2006 Feb 22.

Abstract

Amatoxins are the main poison of the green death cap (Amanita phalloides) and among the most dangerous natural toxins causing hepatic failure. A possible therapeutic approach is the inhibition of the transporting systems mediating the uptake of amatoxins into human hepatocytes, which, however, have yet to be identified. In the current study we tested whether members of the organic anion-transporting polypeptide (OATP) family, localized in the sinusoidal membranes of human hepatocytes, are involved in amatoxin uptake. For this, Madin Darby canine kidney strain II (MDCKII) cells stably expressing human OATP1B3, OATP2B1, or OATP1B1, were assayed for the uptake of 3H-labeled O-methyl-dehydroxymethyl-alpha-amanitin. Under our conditions, only OATP1B3 was able to transport amanitin with a K(m) value of 3.7 microM +/- 0.6 microM. Accordingly, toxin uptake was inhibited by OATP1B3 substrates and inhibitors (cyclosporin A, rifampicin, the quinoline derivatives MK571 ([(3-(3-(2-(7-chloro-2-quinolinyl)ethenyl)phenyl)((3-dimethylamino-3-oxopropyl)thio)methyl)thiopropanoic acid]) and montelukast, the cholecystokinin octapeptide (CCK-8), paclitaxel, and bromosulfophthalein), as well as by some antidotes used in the past for the treatment of human amatoxin poisoning (silibinin dihemisuccinate, penicillin G, prednisolone phosphate, and antamanide). These transport studies are in line with viability assays monitoring the toxic effect of amanitin on the transfected MDCKII cells. Further support for amatoxin transport was found in primary human hepatocytes, expressing OATP1B3, OATP2B1, and OATP1B1, where CCK-8, a substrate specific for OATP1B3, prevented the fragmentation of nucleoli, a lesion typical for amanitin action. In conclusion, we have identified OATP1B3 as the human hepatic uptake transporter for amatoxins; moreover, substrates and inhibitors of OATP1B3, among others rifampicin, may be useful for the treatment of human amatoxin poisoning.

摘要

鹅膏毒素是绿帽菌(毒鹅膏)的主要毒素,是导致肝衰竭的最危险的天然毒素之一。一种可能的治疗方法是抑制介导鹅膏毒素进入人肝细胞的转运系统,但目前尚未明确该转运系统。在本研究中,我们测试了定位于人肝细胞血窦膜上的有机阴离子转运多肽(OATP)家族成员是否参与鹅膏毒素的摄取。为此,我们检测了稳定表达人OATP1B3、OATP2B1或OATP1B1的马德堡-达比犬肾II型(MDCKII)细胞对3H标记的O-甲基-脱羟基甲基-α-鹅膏毒肽的摄取。在我们的实验条件下,只有OATP1B3能够转运鹅膏毒素,其米氏常数(K(m))为3.7 microM ± 0.6 microM。因此,OATP1B3的底物和抑制剂(环孢素A、利福平、喹啉衍生物MK571([(3-(3-(2-(7-氯-2-喹啉基)乙烯基)phenyl)((3-二甲基氨基-3-氧代丙基)硫代)甲基)硫代丙酸])、孟鲁司特、胆囊收缩素八肽(CCK-8)、紫杉醇和溴磺酚酞),以及过去用于治疗人鹅膏毒素中毒的一些解毒剂(水飞蓟宾二半琥珀酸酯、青霉素G、泼尼松龙磷酸盐和抗毒伞肽)均可抑制毒素摄取。这些转运研究与监测鹅膏毒素对转染MDCKII细胞毒性作用的活力测定结果一致。在表达OATP1B3、OATP2B1和OATP1B1的原代人肝细胞中也发现了对鹅膏毒素转运的进一步支持证据,其中OATP1B3的特异性底物CCK-8可防止核仁碎片化,这是鹅膏毒素作用的典型损伤。总之,我们已确定OATP1B3是人肝摄取鹅膏毒素的转运体;此外,OATP1B3的底物和抑制剂,尤其是利福平,可能对治疗人鹅膏毒素中毒有用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验